Gilead To Appeal India Patent Rejection, Hails Regulatory Approval

Gilead logo

Pharmaceutical manufacturer Gilead has given its side to this week’s story of the rejection of its patent on a hepatitis C treatment in India, and it insists it will prevail in making its medicines available in India on its terms.

Key Hepatitis C Patent Rejected In India

Flickr -  DurhamDundee

Today’s rejection by the Patent Office Controller of India of a patent application by Gilead company for a key drug against hepatitis C is being hailed by advocates as a path to dramatically lower costs of treatment for the disease. Hepatitis C has been noteworthy for exorbitantly priced medicines over the past year. A look at the decision shows that a provision in India’s law continues to stop patent applications if they fail to show sufficient novelty and inventive step – and are subject to opposition.

WHO Executive Board To Address Reform, R&D Financing, Ebola, Budget

WHO

The upcoming World Health Organization Executive Board annual January meeting will be 10 days. Included in the list of issues to be addressed are the engagement of the organisation with lobbyists and donors, antimicrobial resistance, and the potential establishment of a pooled fund of voluntary contributions for research and development for diseases primarily affecting developing countries.

CARICOM, Trans-Pacific Partnership, And IP Law & Policy: What Next?

CARICOM logo

The year 2015 has dawned as usual with the fanfare of greater things to come. Caribbean projects are in the pipeline, along with activities to enhance competitiveness and many gallant efforts by well- meaning non-governmental and International organizations. The research has shown, however, that without the impetus of effort that originates from amongst the local innovators, there is no real change and no great advancement.

Top European IP Experts Hail CEIPI’s 50 Years With Vision, Suggestions For IP System

CEIPI logo

The celebration late last year of the 50th anniversary of the Centre de Études Internationales de la Propriété Intellectuelle (CEIPI) at the Université de Strasbourg, France, brought together leading figures in the European IP community. Speakers hailed the origin and successes of the IP system in Europe, and had suggestions for what do better going forward.

Fight Against Ebola Gaining Ground As Vaccines Pass Tests, WHO Says

Ebola virus

The World Health Organization today optimistically announced progress in the search for efficient vaccines to fight the Ebola virus. Tests conducted so far show acceptable safety profiles, and public-private vaccine alliance Gavi has committed to fund Ebola vaccines.

The Latest News In Intellectual Property From ANEPI Ecuador

Cevallos

Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Below is the list of the week’s stories on ANEPI. This week includes a report in English from the WIPO copyright committee. Bienvenido a (ANEPI), La Primera Agencia de Noticias de Propiedad Intelectual del Ecuador: Síguenos http://www.anepi.ec/ANEPIEcuador

India’s Draft IP Policy Shows Major Changes Coming, While Fitting IP System To Local Needs

pm-narendra-modi-launches-make-in-india-campaign-in-delhi

The first draft of a national intellectual property rights policy being developed by a “think tank” of Indian IP experts shows adherence to the country’s principles of bending the IP system to its local needs. But it also shows signs of major change toward more international goals of enforcement and promotion of strong IP rights.

Most-Read IP-Watch Stories In 2014: A Tale Of Staff Issues, India, Hot-Button Topics

world map income

All year long, Intellectual Property Watch expends great energy and resources to bring hundreds of carefully written, detailed stories on policymaking – technical committee meetings, legislation, negotiations, legal cases, and latest reports and papers. But in what is perhaps typical of readers everywhere, many of the best-read IP-Watch stories of 2014 were those few that involved elections and personnel issues and India, followed by a range of hot button issues such as high-priced medicines, copyright and knowledge access, patent valuation, or internet surveillance.